(A) Immunocytochemical and (B) RT-qPCR analyses revealed a marked difference in the (A) protein and (B) mRNA expression levels of RBP2 in thyroid carcinoma K1 cells transfected with RBP2-siRNA, compared with the control cells. (C) Western blot analysis demonstrated a significant difference in the protein levels of RBP2 across the 3 groups of cells. β-actin was used as reference. Transwell assay identified a lower number of (D) invasive and (E) migrated cells in the RBP2-siRNA-transfected cells, compared with the control group. (F) The transfection with RBP2-siRNA affected the tumorigenicity ability of K1 cells, since a lower number of newly formed colonies were observed in the RBP2-siRNA-transfected group, compared with the control group. RT-qPCR, reverse transcription-quantitative polymerase chain reaction; RBP2, retinoblastoma binding protein 2; siRNA, small interfering RNA; RBP2-siRNA, siRNA targeting RBP2; control siRNA, negative control siRNA targeting RBP2; blank group, non transfected cells. **P<0.01 vs. blank group, negative control; *P<0.05 vs. negative control.